Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | IDO1 | P14902 | 4/20 | 0.52 |
| ▸ | DCUN1D1 | Q96GG9 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.44 |
| ▸ | GAA | P10253 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.40 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30940314 | 1.00 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1IDO1DCUN1D1KDM4E | |
| SCHEMBL12615990 | 0.85 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1IDO1DCUN1D1GAA | |
| SCHEMBL11146024 | 0.85 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1IDO1DCUN1D1KDM4E | |
| SCHEMBL12310844 | 0.82 | ALDH1A1 (0.35) | ALDH1A1L3MBTL1IDO1DCUN1D1KDM4E | |
| SCHEMBL9128756 | 0.81 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1IDO1KDM4ESMN1; SMN2 | |
| SCHEMBL8035241 | 0.78 | KDR (0.41) | ALDH1A1DCUN1D1KDM4ENPC1SMN1; SMN2 | |
| SCHEMBL21856971 | 0.78 | KDM4E (0.42) | ALDH1A1L3MBTL1KDM4ENPC1SMN1; SMN2 | |
| SCHEMBL13404775 | 0.78 | JAK2 (0.41) | ALDH1A1KDM4ENPC1SMN1; SMN2GAA | |
| SCHEMBL6919819 | 0.77 | DPP4 (0.47) | ALDH1A1L3MBTL1IDO1 | |
| SCHEMBL23161505 | 0.76 | MEN1 (0.36) | ALDH1A1L3MBTL1IDO1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-57046971-A | — | — | None | — | — | JP | disclosed |
| JP-57171983-A | — | — | None | — | — | JP | disclosed |
| JP-57011975-A | — | — | None | — | — | JP | disclosed |
| JP-56040673-A | — | — | None | — | — | JP | disclosed |
| US-20240402603-A1 | PHOTOSENSITIVE RESIN COMPOSITION, PHOTOSENSITIVE ELEMENT, AND METHOD FOR PRODUCING LAYERED BODY | RESONAC CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | VENTUS THERAPEUTICS U S INC (US) | 2024-11-07 | — | — | US | disclosed |
| US-11993729-B2 | Chemical mechanical polishing composition | BASF SE (DE) | 2024-05-28 | — | — | US | disclosed |
| CN-117980821-A | Photosensitive resin composition, photosensitive element, and method for producing laminate | 株式会社力森诺科 | 2024-05-03 | — | — | CN | disclosed |
| WO-2023190719-A1 | RESIN COMPOSITION, CURED PRODUCT, MULTILAYER BODY, TRANSPARENT ANTENNA AND IMAGE DISPLAY DEVICE | 株式会社レゾナック | 2023-10-05 | — | — | WO | disclosed |
| US-20230227439-A1 | SPAK/OSR INHIBITORS AND METHODS OF USING SAME | YALE UNIVERSITY | 2023-07-20 | — | — | US | disclosed |
| EP-0388967-A1 | Aldose reductase inhibitor | Wakamoto Pharmaceutical Co., Ltd. (JP) | 1990-09-26 | — | — | EP | disclosed |
| JP-S57171983-A | AMINOPHENYLTETRAZOLE DERIVATIVE AND SALT THEREOF | WAKAMOTO PHARMACEUT CO LTD | 1982-10-22 | — | — | JP | disclosed |
| JP-S5746971-A | AMINOPHENYLTETRAZOLE DERIVATIVE AND ITS SALT | WAKAMOTO PHARMACEUT CO LTD | 1982-03-17 | — | — | JP | disclosed |
| JP-S5711975-A | AMINOPHENYLTETRAZOLE DERIVATIVE AND SALT THEREOF | WAKAMOTO PHARMACEUT CO LTD | 1982-01-21 | — | — | JP | disclosed |
| US-4286090-A | BLOWING AGENTS; PROPELLANTS; EXPLOSIVES; IGNITERS | THE DOW CHEMICAL COMPANY (US) | 1981-08-25 | — | — | US | disclosed |
| US-4286090-A | BLOWING AGENTS; PROPELLANTS; EXPLOSIVES; IGNITERS | THE DOW CHEMICAL COMPANY (US) | 1981-08-25 | — | — | US | disclosed |
| JP-S5640673-A | AMINOPHENYLTETRAZOLE DERIVATIVE AND ITS SALT | WAKAMOTO PHARMACEUT CO LTD | 1981-04-16 | — | — | JP | disclosed |
| US-4006127-A | Cationic diazacyanine dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |
| US-3835137-A | FIBRINOLYTIC TETRAZOLO(1,5-C)QUINAZOLINES | DOW CHEMICAL CO | 1974-09-10 | — | — | US | disclosed |
| US-3835138-A | BRONCHODILATOR 5,6-DIHYDRO-TETRAZOLO(1,5-C) QUINAZOLINES | DOW CHEMICAL CO | 1974-09-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240368131-A1 | OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF | NLRP3, NLRP1, NOD1 | ALDH1A1 4026/4885L3MBTL1 2986/4885IDO1 1883/4885 |
| US-20230227439-A1 | SPAK/OSR INHIBITORS AND METHODS OF USING SAME | OXSR1, VHL, TTK | ALDH1A1 3184/4885L3MBTL1 1231/4885IDO1 4725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.